Updated progression of honokiol in lung cancer treatment

肺癌 和厚朴酚 激酶 癌症研究 癌症 肺癌的治疗 药理学 生物 医学 肿瘤科 内科学 生物化学
作者
Ziwei Gao,Yuping Yang,Na Huang,Wei Zhao
出处
期刊:Journal of Pharmacy and Pharmacology [Oxford University Press]
被引量:1
标识
DOI:10.1093/jpp/rgaf007
摘要

Abstract Objectives Despite significant advancements in innovative therapy, lung cancer continues to have an unexpectedly low 5-year survival rate. This necessitates the urgent development of novel and effective therapies. One such potential therapy is Honokiol (HNK, C18H18O2), a biphenolic natural compound isolated from the leaves and bark of Magnolia plant species. The objective of this review is to examine the various studies supporting the anti-lung cancer effects of HNK and its potential use in the treatment of lung cancer. Key findings Emerging research has shown that HNK possesses a range of pharmacological characteristics that make it a promising agent in the fight against lung cancer. Specifically, HNK has been found to regulate various molecular targets, including the activation of pro-apoptotic factors and the suppression of anti-apoptotic proteins and different transcription factors. It also downregulates various enzymes, chemokines, cell surface adhesion molecules, and cell cycle proteins. Additionally, HNK inhibits the activity of protein tyrosine kinases and serine/threonine kinases. These effects contribute to its ability to efficiently prevent the progression of lung cancer, either solely or in combination with other therapeutic strategies. Furthermore, several nanotechnologies have been employed to modify HNK for the treatment of lung cancer, enhancing its potential efficacy. Summary In summary, Honokiol (HNK) is a biphenolic natural compound with significant anti-lung cancer properties. Its pharmacological characteristics, including the regulation of various molecular targets and the inhibition of key enzymes and kinases, make it a promising agent for the treatment of lung cancer. Emerging research supports its ability to prevent the progression of lung cancer, either alone or in combination with other therapies. Additionally, nanotechnologies have been used to modify HNK, potentially enhancing its efficacy in the treatment of lung cancer. This review highlights the various studies documenting the anti-lung cancer effects of HNK, underscoring its potential as a novel and effective therapy for this deadly disease.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
可爱的函函应助GINNY采纳,获得10
1秒前
彭于晏应助冬至采纳,获得10
2秒前
沐杨完成签到,获得积分10
2秒前
勤劳的紫寒完成签到,获得积分20
2秒前
3秒前
跃迁的电子完成签到,获得积分10
3秒前
汉堡包应助科研通管家采纳,获得10
3秒前
3秒前
今后应助科研通管家采纳,获得10
3秒前
香蕉觅云应助科研通管家采纳,获得10
4秒前
33发布了新的文献求助10
4秒前
科研通AI2S应助科研通管家采纳,获得10
4秒前
4秒前
Lucas应助科研通管家采纳,获得10
4秒前
4秒前
4秒前
昏睡的蟠桃应助科研通管家采纳,获得200
4秒前
奇遇发布了新的文献求助10
4秒前
4秒前
打打应助科研通管家采纳,获得10
4秒前
4秒前
万能图书馆应助ayutaoo采纳,获得10
4秒前
4秒前
5秒前
完美世界应助科研通管家采纳,获得30
5秒前
Hello应助科研通管家采纳,获得30
5秒前
可爱的函函应助此生采纳,获得10
5秒前
乐乐应助科研通管家采纳,获得10
5秒前
天天快乐应助科研通管家采纳,获得10
5秒前
5秒前
dew应助科研通管家采纳,获得50
5秒前
情怀应助BZPL采纳,获得10
5秒前
在水一方应助科研通管家采纳,获得10
5秒前
6秒前
科目三应助科研通管家采纳,获得10
6秒前
打打应助科研通管家采纳,获得20
6秒前
6秒前
思源应助科研通管家采纳,获得10
6秒前
英姑应助科研通管家采纳,获得10
6秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
The Multiple Self-States Drawing Technique 600
Organizational Behavior 510
Management and the Arts 510
Matrix Methods in Data Mining and Pattern Recognition Second Edition 510
Rosenblum, Global Change Biology 500
CLSI VET01S-2024 Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From Animals (7th Ed) 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 化学工程 工程类 有机化学 物理 复合材料 生物化学 内科学 细胞生物学 基因 遗传学 免疫学 冶金 光电子学 癌症研究
热门帖子
关注 科研通微信公众号,转发送积分 7769181
求助须知:如何正确求助?哪些是违规求助? 9312341
关于积分的说明 20328283
捐赠科研通 7354496
什么是DOI,文献DOI怎么找? 3315979
关于科研通互助平台的介绍 2464892
邀请新用户注册赠送积分活动 2330552